{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:04:48Z","timestamp":1784689488427,"version":"3.55.0"},"reference-count":66,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1586\/14760584.2.4.571","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T11:32:47Z","timestamp":1105615967000},"page":"571-582","source":"Crossref","is-referenced-by-count":9,"title":["Neisseria meningitidis serogroup A vaccines: an overview"],"prefix":"10.1586","volume":"2","author":[{"given":"Stefania","family":"Vergnano","sequence":"first","affiliation":[{"name":"Department of Child Health, St. George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK. pheath@sghms.ac.uk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Heath","sequence":"additional","affiliation":[{"name":"Department of Child Health, St. George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, UK. pheath@sghms.ac.uk"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"e_1_2_1_5_1","first-page":"317","article-title":"Lakes area (Burundi, Rwanda, United Republic of Tanzania) \u2014 update","volume":"77","author":"Meningococcal disease, Great","year":"2002","unstructured":"Meningococcal disease, Great Lakes area (Burundi, Rwanda, United Republic of Tanzania) \u2014 update. Wkly Epidemiol Rec. 77,317 (2002).","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.061386098"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08416-7"},{"key":"e_1_2_1_8_1","first-page":"155","article-title":"Tappero JW. Meningococcal vaccines. Infect. Dis. Gun","volume":"15","author":"Rosenstein NE","year":"2001","unstructured":"Rosenstein NE, Fischer M, Tappero JW. Meningococcal vaccines. Infect. Dis. Gun. N. AM 15,155\u2013169 (2001).","journal-title":"N. AM"},{"key":"e_1_2_1_9_1","first-page":"1307","article-title":"Artenstein MS","volume":"129","author":"Goldschneider I","year":"1969","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp. Med 129,1307\u20131326 (1969).","journal-title":"Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp. Med"},{"key":"e_1_2_1_10_1","unstructured":"\u2022\u2022Classic paper describing immunityto meningococci."},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"Rosestein N Perkins B Stephens D Popovic T Highes J. Medical progress: meningococcal disease. N. Engl. Med 344 1378\u20131388 (2001).","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1997.11813203"},{"key":"e_1_2_1_13_1","first-page":"135","article-title":"Hausman B. Priority during a meningitis epidemic: vaccination or treatment? Buff","volume":"76","author":"Veeken H","year":"1998","unstructured":"Veeken H, Ritmeijer K, Hausman B. Priority during a meningitis epidemic: vaccination or treatment? Buff. World I-kalth Chan. 76, 135\u2013141 (1998).","journal-title":"World I-kalth Chan"},{"key":"e_1_2_1_14_1","unstructured":"Frasch C. Meningococcal Vaccines: past present and future. In: Meningococal disease. Wiley Chicester UK 246\u2013283 (1995)."},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","unstructured":"Molesworth AM Thomson MC Connor SJ et al. Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans. I? Soc. Trop. Med 48: 96 242\u2013249 (2002).","DOI":"10.1016\/S0035-9203(02)90089-1"},{"key":"e_1_2_1_16_1","first-page":"259","article-title":"Meningococcal disease","volume":"23","author":"Memish ZA","year":"2002","unstructured":"Memish ZA, Alrajhi AA. Meningococcal disease. Saudi Med. 23,259\u2013264 (2002).","journal-title":"Saudi Med"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Kwara A Adegbola RA Corrah PT et al. Meningitis caused by a serogroup W135 clone of the ET-37 complex of Nisseria meningitidisin West Africa. Tivp. Med. Int. Health. 3 742-746 (1998).","DOI":"10.1046\/j.1365-3156.1998.00300.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","unstructured":"MacLennan JM Urwin R Obaro S Griffiths D Greenwood B Maiden MC. Carriage of serogroup W-135 ET-37 meningococci in the Gambia: implications for immunisation policy? Lancet 356 1078 (2000).","DOI":"10.1016\/S0140-6736(00)02734-3"},{"key":"e_1_2_1_19_1","unstructured":"Lepow ML Perkins BA Hughes PA Poolman JT. Meningococcal vaccines. In: Vaccines 3n1 Edition. Plotkin SA Orenstein WA (Eds). WB Saunders PA USA 711\u2013724 (1999)."},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"Ceesay SJ Allen SJ Menon A et al. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect. Dis. 167 1212-1216 (1993).","DOI":"10.1093\/infdis\/167.5.1212"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90224-7"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.19.1685"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00139-5"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92403-0"},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Patel M Lee CK. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. Cochrane Database Syst. Rev 3 CD001093 (2001).","DOI":"10.1002\/14651858.CD001093"},{"key":"e_1_2_1_26_1","unstructured":"\u2022Systematic review of studies of polysaccharide vaccines for preventing meningococcal A disease."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/29.5.933"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05492-7"},{"key":"e_1_2_1_29_1","first-page":"287","article-title":"Paquet C","volume":"358","author":"Lewis R","year":"2001","unstructured":"Lewis R, Nathan N, Diarra L, Belanger F, Paquet C. Timely detection of meningococcal meningitis epidemics in Africa. Lancet 358,287\u2013293 (2001).","journal-title":"Timely detection of meningococcal meningitis epidemics in Africa. Lancet"},{"key":"e_1_2_1_30_1","unstructured":"Detecting meningococcal meningitis epidemics in highly-endemic African countries. Wkly Epidemiol Rec. 75 306\u2013309 (2000)."},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03366-8"},{"key":"e_1_2_1_32_1","first-page":"1051","article-title":"Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa. Pediati: Infect","volume":"118","author":"Miller MA","year":"1999","unstructured":"Miller MA, Wenger J, Rosenstein N, Perkins B. Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa. Pediati: Infect. Ds. 118, 1051\u20131059 (1999).","journal-title":"Ds"},{"key":"e_1_2_1_33_1","unstructured":"\u2022An analysis of different prevention strategies."},{"key":"e_1_2_1_34_1","first-page":"2252","article-title":"Massougbodji A","volume":"355","author":"de Chabalier F","year":"2000","unstructured":"de Chabalier F, Chippaux JP, Massougbodji A. Meningococcal immunisation in Ghana. Lancet355, 2252\u20132253 (2000).","journal-title":"Meningococcal immunisation in Ghana. Lancet"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)72750-1"},{"key":"e_1_2_1_36_1","first-page":"499","article-title":"Cisse L, Chippaux JP Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96","volume":"77","author":"Campagne G","year":"1999","unstructured":"Campagne G, Schuchat A, Djibo S, Ousseini A, Cisse L, Chippaux JP Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World I-kalth Organ. 77, 499\u2013508 (1999).","journal-title":"Bull World I-kalth Organ"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60508-9"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1999.11813450"},{"key":"e_1_2_1_39_1","first-page":"1205","article-title":"Au HJ","volume":"48","author":"Bovier PA","year":"1999","unstructured":"Bovier PA, Wyss K, Au HJ. A cost- effectiveness analysis of vaccination strategies against N meningitidis meningitis in sub-Saharan African countries. Soc. Sc]. Med 48, 1205\u20131220 (1999).","journal-title":"A cost- effectiveness analysis of vaccination strategies against N meningitidis meningitis in sub-Saharan African countries. Soc. Sc]. Med"},{"key":"e_1_2_1_40_1","first-page":"563","article-title":"Recent developments in bacterial conjugate vaccines","volume":"47","author":"Goldblatt D","year":"1998","unstructured":"Goldblatt D. Recent developments in bacterial conjugate vaccines. J Med. Mavbiol 47,563\u2013567 (1998).","journal-title":"J Med. Mavbiol"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00552-1"},{"key":"e_1_2_1_42_1","unstructured":"International co-ordinating group on vaccine provision for epidemic meningitis control. Report of the 7th meeting. WHO Geneva Switzerland (2001)."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13494-0"},{"key":"e_1_2_1_44_1","unstructured":"\u2022\u2022Exciting developments for an affordableconjugate vaccine for Africa."},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.8.3391-3395.1994"},{"key":"e_1_2_1_46_1","first-page":"1499","article-title":"Safety and immunogenicity of a serogroups A\/C Neisseria meningitidis oligosaccharide\u2014protein conjugate vaccine in young children","volume":"275","author":"Lieberman JM","year":"1996","unstructured":"Lieberman JM, Chiu SS, Wong VK et al. Safety and immunogenicity of a serogroups A\/C Neisseria meningitidis oligosaccharide\u2014protein conjugate vaccine in young children. A randomized controlled trial. JAIVIA 275, 1499\u20131503 (1996).","journal-title":"A randomized controlled trial. JAIVIA"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200002000-00013"},{"key":"e_1_2_1_48_1","first-page":"632","article-title":"Kumah S, Leach A et al","volume":"71","author":"Twumasi PA","year":"1995","unstructured":"Twumasi PA, Jr., Kumah S, Leach A et al. A trial of a group A plus group C meningococcal polysaccharide\u2014protein conjugate vaccine in African infants. j Infect. Dis. 71,632\u2013638 (1995).","journal-title":"A trial of a group A plus group C meningococcal polysaccharide\u2014protein conjugate vaccine in African infants. j Infect. Dis"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.6.1360"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.1.200"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268899003787"},{"key":"e_1_2_1_52_1","doi-asserted-by":"crossref","unstructured":"MacLennan J Obaro S Deeks J et al Immunologic memory 5 years after meningococcal A\/C conjugate vaccination in infancy. Infect. Dir. 183 97-104 (2001).","DOI":"10.1086\/317667"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1086\/322790"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200210000-00019"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00318-3"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.5.982"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00180-8"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.7.4337-4341.2001"},{"key":"e_1_2_1_59_1","first-page":"2842","article-title":"New opportunities for prevention of meningococcal disease","volume":"283","author":"Perkins BA","year":"2000","unstructured":"Perkins BA. New opportunities for prevention of meningococcal disease. PIMA 283,2842\u20132843 (2000).","journal-title":"PIMA"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00390-4"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441807"},{"key":"e_1_2_1_62_1","doi-asserted-by":"crossref","unstructured":"Bethell D Pollard A. Meningococcal vaccines. Exper t Rev Vaccinesl 75\u201384 (2002).","DOI":"10.1586\/14760584.1.1.75"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.9.4955-4959.1999"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.10.5417-5426.1999"},{"key":"e_1_2_1_65_1","doi-asserted-by":"crossref","unstructured":"Robbins JB Schneerson R Gotschlich EC. A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine. Pediatr. Infect. Dis. .1. 19(10) 945\u2013953 (2000).","DOI":"10.1097\/00006454-200010000-00001"},{"key":"e_1_2_1_66_1","unstructured":"\u2022A summary of the arguments for routine vaccination with polysaccharide vaccine."},{"key":"e_1_2_2_2_1","unstructured":"WHO: World Health Organization who.int\/emc\/diseases\/meningitis\/ index.html."},{"key":"e_1_2_2_3_1","unstructured":"WHO: 'Control of epidemic meningococcal disease. WHO practical guidelines. 2nd edition' 1998 www.who.int\/emc-documents\/ meningitis\/docs\/whoemcbac983.pdf."},{"key":"e_1_2_2_4_1","unstructured":"\u2022WHO guidelines for epidemics."},{"key":"e_1_2_2_5_1","unstructured":"GAVI Global alliance for vaccines and Immunisation www.vaccinealliance.org\/home\/ index.php."}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14760584.2.4.571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:57:37Z","timestamp":1769716657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14760584.2.4.571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1586\/14760584.2.4.571"],"URL":"https:\/\/doi.org\/10.1586\/14760584.2.4.571","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}